Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis Clinical Trial

Official title:
A Randomized, Open-Label, Multiple Dose, Two-Period Crossover Study Evaluating Maximum Use 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% in Men and Women With Primary Axillary Hyperhidrosis

Status Not yet recruiting

Clinical Trial Summary

The aim of this study is to investigate the safety, tolerability and efficacy of 1% GPB Cream compared to Qbrexza® (glycopyrronium) cloth, 2.4%, for topical use under maximum use conditions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04159610
Study type	Interventional
Source	Dr. August Wolff GmbH & Co. KG Arzneimittel
Contact	Clarissa Masur, PhD
Phone	+49 521 8808 319
Email	clarissa.masur@drwolffgroup.com
Status	Not yet recruiting
Phase	Phase 2
Start date	July 1, 2022
Completion date	April 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03627468` - A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis	Phase 3
Completed	`NCT03658616` - Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.	Phase 3
Completed	`NCT02286765` - Ulthera® System for Treating Axillary Hyperhidrosis	N/A
Completed	`NCT04599907` - Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating	N/A
Completed	`NCT03037788` - Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis	Phase 1
Terminated	`NCT01722461` - A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis	N/A
Completed	`NCT05863104` - Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis	Phase 2
Completed	`NCT02823340` - Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis	N/A
Completed	`NCT01799824` - Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis	Phase 2
Completed	`NCT03785587` - A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis	Phase 2
Completed	`NCT03054480` - Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis	N/A